Amyloidomas of the nervous system: A monoclonal B-cell disorder with monotypic amyloid light chain λ amyloid production

Cancer

Volumn 82, Issue 2, 1998, Pages 362-374

  Laeng, R Hubert ^a   Altermatt, Hans Jörg ^b   Scheithauer, Bernd W ^c   Zimmermann, Dieter R ^d  

^a Kantonsspital ^*  (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Amyloidoma; B cell; Central nervous system; Neoplasm; Peripheral nervous system

Indexed keywords

AMYLOID; IMMUNOGLOBULIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY; PREALBUMIN;

AMYLOIDOSIS; ARTICLE; BRAIN INJURY; CANCER GRADING; CASE REPORT; CELL CLONING; CELL POPULATION; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CELL; PLASMACYTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRIGEMINAL NERVE; TUMOR DIAGNOSIS; TUMOR LOCALIZATION;

ADULT; AGED; AMYLOID; AMYLOID NEUROPATHIES; AMYLOIDOSIS; ANTIBODIES; B-LYMPHOCYTES; BETA 2-MICROGLOBULIN; BRAIN DISEASES; CHOROID PLEXUS; CLONE CELLS; COLORING AGENTS; CONGO RED; CRANIAL NERVE DISEASES; DNA PROBES; FEMALE; FLUORESCENT DYES; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IN SITU HYBRIDIZATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PLASMA CELLS; PREALBUMIN; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; SERUM AMYLOID P-COMPONENT; THIAZOLES; TOMOGRAPHY, X-RAY COMPUTED; TRIGEMINAL GANGLION;

EID: 0031985030     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980115)82:2<375::AID-CNCR18>3.0.CO;2-W     Document Type: Article

References (78)

1. Borghi G, Tagliabue G. Primary amyloidosis of the gasserian ganglion. Acta Neurol Scand 1961;37:105-10.
2. Bornemann A, Bohl J, Hey O, Störkel S, Gamm H, Müller-Forell W, et al. Amyloidoma of the gasserian ganglion as a cause of symptomatic neuralgia of the trigeminal nerve: report of three cases. J Neurol 1993;241:10-4.
3. Cohen M, Lanska D, Roessmann U, Karaman B, Ganz E, Whitehouse P, et al. Amyloidoma of the CNS. I. Clinical and pathologic study. Neurology 1992;42:2019-23.
4. Daly DD, Love JG, Dockerty MB. Amyloid tumor of the gasserian ganglion. Report of case. J Neurosurg 1957;14:347-52.
5. DeCastro S, Sparks JT, Lapey JD, Freidberg SR. Amyloidoma of the gasserian ganglion. Surg Neurol 1976;6:357-9.
6. Eriksson L, Sletten K, Benson L, Westermark P. Tumour-like localized amyloid of the brain is derived from immunoglobulin light chain. Scand J Immunol 1993;37:623-6.
7. Gabet JY, Vital Durand D, Bady B, Kopp N, Sindou M, Levrat R. Pseudo-tumeur amyloïde du nerf sciatique. Rev Neurol (Paris) 1989;145:872-6.
8. Harris JH, Rayport M. Primary "cerebral amyloidoma" [abstract]. J Neuropathol Exp Neurol 1979;38:318.
9. Hori A, Kitamoto T, Tateishi J, Hann P, Friede RL. Focal intracerebral accumulation of a novel type of amyloid protein. An early stage of cerebral amyloidoma? Acta Neuropathol (Beri) 1988;76:212-5.
10. Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine 1975;54:271-99.
11. Lampert P. Tumor forming atypical amyloidosis of the choroid plexus with invasion of the cerebral white matter. J Neuropathol Exp Neurol 1958;17:604-11.
12. Lee J, Krol G, Rosenblum M. Primary amyloidoma of the brain: CT and MR presentation. AJNR Am J Neuroradiol 1995;16:712-4.
13. Linke RP, Gerhard L, Lottspeich F. Brain-restricted amyloidoma of immunoglobulin λ-light chain origin clinically resembling multiple sclerosis. Biol Chem Hoppe Seyler 1992;373:1201-9.
14. Matsumoto T, Tani E, Maeda Y, Natsume S. Amyloidomas in the cerebellopontine angle and jugular foramen. Case report. J Neurosurg 1985;62:592-6.
15. O'Brien TJ, McKelvie PA, Vrodos N. Bilateral trigeminal amyloidoma: an unusual case of trigeminal neuropathy with a review of the literature. Case report. J Neurosurg 1994;81:780-3.
16. Peters G. Über Paramyloidose des Gehirns. Verh Dtsch Ges Pathol 1948;32:83-9.
17. Pizov G, Soffer D. Amyloid tumor (amyloidoma) of a peripheral nerve. Arch Pathol Lab Med 1986;110:969-70.
18. Saltykow S. Zur Frage des lokalen Amyloids der Hirngefäße. Virchows Arch A Pathol Anat Histopathol 1935;295:590.
19. Schröder R, Linke RP, Voges J, Heindel W, Sturm V. Intracerebral Al amyloidoma diagnosed by stereotactic biopsy. Clin Neuropathol 1995;14:347-50.
20. Spaar FW, Goebel HH, Volles E, Wickboldt J. Tumor-like amyloid formation (amyloidoma) in the brain. J Neurol 1981;224:171-82.
21. Townsend JJ, Tomiyasu U, MacKay A, Wilson CB. Central nervous system amyloid presenting as a mass lesion. Report of two cases. J Neurosurg 1982;56:439-42.
22. Vidal RG, Ghiso J, Gallo G, Cohen M, Gambetti P-L, Frangione B. Amyloidoma of the CNS. II. Immunohistochemical and biochemical study. Neurology 1992;42:2024-8.
23. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80.
24. Pringle JH, Ruprai AK, Primrose L, Keyte J, Potter L, Close P, et al. In situ hybridization of immunoglobulin light chain mRNA in paraffin sections using biotinylated or hapten-labelled oligonucleotide probes. J Pathol 1990;162:197-207.
25. Segal GH, Jorgensen T, Scott M, Braylan RC. Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoproliferative disorders of nonfollicular center cell type. Hum Pathol 1994;25:1269-75.
26. Zimmermann DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 1989;8:2975-81.
27. Glenner GG. Amyloid deposits and amyloidosis. The β-fibrilloses (first of two parts). N-Engl J Med 1980;302:1283-92.
28. Glenner GG. Amyloid deposits and amyloidosis. The β-fibrilloses (second of two parts). N Engl J Med 1980;302:1333-43.
29. Stone MJ. Amyloidosis: a final common pathway for protein deposition in tissues. Blood 1990;75:531-45.
30. Castaño EM, Frangione B. Alzheimer's disease from the perspective of the systemic and localized forms of amyloidosis. Brain Pathol 1991;1:263-71.
31. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-90.
32. Sillus M, Saeger W, Linke RP, Müller D, Voigt C. Cerebral amyloid angiopathy. Frequency, significance and immunohistochemistry. Zentralbl Pathol 1993;139:207-15.
33. Dewji NN, Singer SJ. Genetic clues to Alzheimer's disease. Science 1996;271:159-60.
34. Vinters HV, Wang ZZ, Secor DL. Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol 1996;6:179-95.
35. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF, et al. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell 1983;35:349-58.
36. Stahl N, Prusiner SB. Prions and prion proteins. FASEB J 1991;5:2799-807.
37. Reilly MM, Staunton H. Peripheral nerve amyloidosis. Brain Pathol 1996;6:163-77.
38. Kelly JJ, Kyle RA, O'Brien PC, Dyck PJ. The natural history of peripheral neuropathy in primary systemic amyloidosis. Ann Neurol 1979;6:1-6.
39. Maury CPJ, Teppo A-M, Karinemi A-L, Koeppen AH. Amyloid fibril protein in familial amyloidosis with cranial neuropathy and corneal lattice dystrophy (FAP type IV) is related to transthyretin. Am J Clin Pathol 1988;89:359-64.
40. Reilly MM, King RHM. Familial polyneuropathy. Brain Pathol 1993;3:165-76.
41. Little KH, Lee EL, Frenkel EP. Cranial nerve deficits due to amyloidosis associated with plasma cell dyscrasia. South Med J 1986;79:677-81.
42. McLeod JG, Walsh JC. Neuropathies associated with paraproteinemias and dysproteinemias. In: Dyck PJ, Thomas PK, Lambert EH, editors. Peripheral neuropathy. Philadelphia: W.B. Saunders Co., 1975:1012-29.
43. Traynor AE, Gertz MA, Kyle RA. Cranial neuropathy associated with primary amyloidosis. Ann Neurol 1991;29:451-4.
44. Krishnan J, Chu W-S, Elrod JP, Frizzera G. Tumoral presentation of amyloidosis (amyloidomas) in soft tissues. A report of 14 cases. Am J Clin Pathol 1993;100:135-44.
45. Pambuccian SE, Horyd ID, Cawte T, Huvos AG. Amyloidoma of bone, a plasma cell/plasmaeytoid neoplasm. Report of three cases and review of the literature. Am J Surg Pathol 1997;21:179-86.
46. Ross LV, Ross GJ, Mesgarzadeh M, Edmonds PR, Bonakdarpour A. Hemaodialysis-related amyloidosis of bone. Radiology 1991;178:263-5.
47. Glenner GG, Terry W, Harada M, Isersky G, Fage D. Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science 1971;172:1150-1.
48. Ishihara T, Takahashi M, Koga M, Yokota T, Yamashita Y, Uchino F. Amyloid fibril formation in the rough endoplasmic reticulum of plasma cells from a patient with localized AX amyloidosis. Lab Invest 1991;64:265-71.
49. Glenner GG, Eanes ED, Page DL. The relation of the properties of congo red-stained amyloid fibrils to the β-conformation. J Histochem Cytochem 1972;20:821-6.
50. λVI subgroup of human light chains with amyloidosis AL (λ). J Clin Invest 1982;70:453-60.
51. Solomon A, Schmidt W, Havemann K. Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins. J Immunol 1976;117:1010-4.
52. Isobe T, Takatsuki K, Tishendorf FW, Birken S, Osserman EF. Plasma cell myeloma, hyperviscosity and amyloidosis associated with a serum IgG3 lambda and urinary excretion of two fragments related to the variable portion of lambda light chains. Clin Immunol Immunopathol 1981;19:55-66.
53. Isobe T, Osserman EF. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. N Engl J Med 1974;290:473-7.
54. Michaels L, Hyams VJ. Amyloid in localized deposits and plasmacytomas of the respiratory tract. J Pathol 1979;128:29-38.
55. Bhagwandeen BS, Taylor S. Primary localized amyloidoma of the bladder with a monoclonal plasma cell infiltrate. Pathology 1988;20:67-9.
56. Lucas DR, Knox F, Davies S. Apparent monoclonal origin of lymphocytes and plasma cells infiltrating ocular adnexal amyloid deposits: report of 2 cases. Br J Ophthalmol 1982;66:600-6.
57. Schaldenbrand JD, Keren DF. IgD amyloidosis in IgD-λ monoclonal conjunctival amyloidosis. A case report. Arch Pathol Lab Med 1983;107:626-8.
58. Ferreiro JA, Bhuta S, Nieberg RK, Verity MA. Amyloidoma of the skull base. Arch Pathol Lab Med 1990;114:974-6.
59. Ünal F, Hepgül K, Bayindir Ç, Bilge T, Îmer M, Turantan Î. Skull base amyloidoma. Case report. J Neurosurg 1992;76:303-6.
60. Dickman CA, Sonntag VKH, Johnson P, Medina M. Amyloidoma of the cervical spine: a case report. Neurosurgery 1988;22:419-22.
61. Leeson MC, Rechtine GR, Makley JT, Carter JR. Primary amyloidoma of the spine. A case report and review of the literature. Spine 1985;10:303-6.
62. Hegarty JL, Rao VM. Amyloidoma of the nasopharynx: CT and MR findings. AJNR Am J Neuroradiol 1993;14:215-8.
63. Bohl J, Steinmetz H, Storkel S. Age-related accumulation of congophilic fibrillar inclusions in endocrine cells. Virchows A Arch Pathol Anat Histopathol 1991;419:51-8.
64. Eriksson L, Westermark P. Characterization of intracellular amyloid fibrils in the human choroid plexus epithelial cells. Acta Neuropathol (Beri) 1990;80:597-603.
65. Tu GF, Southwell BR, Schreiber G. Species specificity and developmental patterns of expression of the beta amyloid precursor protein (APP) gene in brain, liver and chroroid plexus in birds. Comp Biochem Physiol [B] 1992;101:391-8.
66. Isaacson PG, Norton AJ. Extranodal lymphomas. Edinburgh: Churchill Livingstone, 1994:11-14,23,38,221.
67. Ellie E, Vergier B, Duche B, Rivel J, Vital C, Loiseau P. Local amyloid deposits in a primary central nervous system lymphoma. A study of a stereotactic brain biopsy. Clin Neuropathol 1990;9:231-3.
68. Mancardi GL, Mandybur TI. Solitary intracranial plasmacytoma. Cancer 1983;51:2226-33.
69. Grant JW, Isaacson PG. Primary central nervous system lymphoma. Brain Pathol 1991;2:97-109.
70. Smith WJ, Garson JA, Bourne SP, Kemshead JT, Coakham HB. Immunoglobulin gene rearrangement and antigenic profile confirm B cell origin of primary cerebral lymphoma and indicate mature phenotype. J Clin Pathol 1988;41:128-32.
71. Radi MJ, Foucar E, Palmer CH, Gooding RA. Malignant lymphoma arising in a large congenital neurofibroma of the head and neck. Cancer 1988;61:1667-73.
72. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
73. Diss TC, Pan L, Peng HZ, Wotherspoon AC, Isaacson PG. Sources of DNA for detecting B cell monoclonality using PCR. J Clin Pathol 1994;47:493-6.
74. Wotherspoon AC, Doglioni C, Diss TC, Pan LX, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue after eradication of Helicobacter pylori. Lancet 1993;342:575-7.
75. Abbas AK. Die and let live: eliminating dangerous lymphocytes. Cell 1996;84:655-7.
76. Hinton DR, Polk RK, Linse KD, Weiss MH, Kovacs K, Garner JA. Characterization of spherical amyloid protein from a prolactin-producing pituitary adenoma [abstract]. J Neuropathol Exp Neurol 1996;55:652.
77. Marcon G, Giaccone G, Canciani B, Caiola L, Rossi G, De Gioia L, et al. Neurotoxicity of A βPP peptide other than Aβ. J Neuropathol Exp Neurol 1996;55:639.
78. Wotherspoon AC, Finn T, Isaacson PG. Numerical abnormalities of chromosomes 3 and 7 in lymphomas of the mucosa-associated lymphoid tissue and the splenic marginal zone. Lab Invest 1994;70:124A.